Company intelligence / Profile preview

Aptus Clinical

Alderley Edge, England, United Kingdomprnewswire.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Aptus Clinical specialized in designing and delivering early-phase clinical studies, particularly in oncology, rare diseases, and advanced therapies such as cell and gene therapies. The company was recognized for its expertise in complex trial design and execution, strong academic links, and successful partnerships with biotech/pharma clients including Artelo Biosciences for the ART27.13 program. In May 2022 it was acquired by Catalyst Clinical Research to expand their combined global reach.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Cell therapyGene therapySmall moleculeBiologic
Industry: Contract Research Organization

Partnerships

Artelo BiosciencesiMATCH Advanced Therapy Centre Hub consortium partnerCell and Gene Therapy Catapult supplier

Beyond the preview

Go deeper on Aptus Clinical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aptus Clinical.

Explore the full profile